Multicenter study to evaluate the efficacy of 1L Ascorbic acid PEG plus linaclotide for bowel preparatio
Not Applicable
- Conditions
- patients who require colonoscopycolonoscopyD003113
- Registration Number
- JPRN-jRCTs051210162
- Lead Sponsor
- Fujiwara Yasuhiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 1464
Inclusion Criteria
1) patients who were scheduled for elective colonoscopy
2) patients who aged over 20 years old and under 85 years old
3) patients who were able to fill in the informed consent form for participation
Exclusion Criteria
1) severe heart failure (NYHA class III or IV)
2) severe hepatic failure (Child-Pugh C)
3) active inflammatory bowel disease
4) dementia
5) allergy to Moviprep, sennoside or linaclotide
6) advanced colorectal cancer
7) intestinal resection
8) past history of participance in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method